Home › Arca Biopharma Upgraded to "Buy" by Zacks
 

Keywords :   


Arca Biopharma Upgraded to "Buy" by Zacks

2015-09-06 11:55:06| Biotech - Topix.net

The firm currently has a $1.25 target price on the biopharmaceutical company's stock. Zacks 's price target would suggest a potential downside of 80.47% from the stock's previous close.

Tags: buy upgraded arca zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »